Biocon Expands Into Middle East With Tabuk Partnership

Tabuk Will Commercialize Select Biocon Generics In The Region

 
• By Chloe Kent

Biocon is set to bolster its planned expansion into the MENA region through a partnership with Saudi firm Tabuk Pharmaceuticals, which will commercialize select Biocon generics in the Middle East.

Biocon logo under magnifying glass
Biocon is expanding into the Middle East through a partnership with Tabuk Pharmaceuticals • Source: Alamy

India’s Biocon, Ltd. has announced a partnership with Tabuk Pharmaceutical Manufacturing Co., a leading pharmaceutical firm in the Middle East and North Africa region, to commercialize select Biocon generics in the Middle East.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business